{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:12:55Z","timestamp":1786378375545,"version":"build-2736575974"},"reference-count":50,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2023,4,25]]},"DOI":"10.1272\/jnms.jnms.2023_90-216","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T22:13:49Z","timestamp":1685398429000},"page":"157-164","source":"Crossref","is-referenced-by-count":19,"title":["Depression as a Prodromal Symptom of Neurodegenerative Diseases"],"prefix":"10.1272","volume":"90","author":[{"given":"Amane","family":"Tateno","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nogami","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sakayori","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Nippon Medical School"},{"name":"Tama Chuo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. Rouchell AM. Major depression in primary care. Ochsner J. 2000 Apr;2 (2):79-84."},{"key":"2","unstructured":"2. Miyoshi K. Depression associated with physical illness. JAMJ. 2001;44 (6):279-82."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nogami A, Yamazaki M, Saito Y, et al. Early stage of progressive supranuclear palsy: A neuropathological study of 324 consecutive autopsy cases. J Nippon Med Sch. 2015;82 (6):266-73.","DOI":"10.1272\/jnms.82.266"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mirza SS, de Bruijin RF, Direk N, et al. Depressive symptoms predict incident dementia during short- but not long-term follow-up period. Alzheimers Dement. 2014 Oct;10 (5 Suppl):S323-9.","DOI":"10.1016\/j.jalz.2013.10.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wyman-Chick KA, O&apos;Keefe LR, Weintraub D, et al. Prodromal dementia with Lewy bodies: Evolution of symptoms and predictors of dementia onset. J Geriatr Psychiatry Neurol. 2022 Jul;35 (4):527-34.","DOI":"10.1177\/08919887211023586"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson&apos;s disease: A register study. Mov Disord. 2003 Apr;18 (4):414-8.","DOI":"10.1002\/mds.10387"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sweet RA, Hamilton RL, Butters MA, et al. Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology. 2004 Dec;29 (12):2242-50.","DOI":"10.1038\/sj.npp.1300554"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Uchikado H, Lin WL, DeLucia MW, Dickson DW. Alzheimer disease with amygdala Lewy bodies: A distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol. 2006 Jul;65 (7):685-97.","DOI":"10.1097\/01.jnen.0000225908.90052.07"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shioya A, Saito Y, Arima K, et al. Neurodegenerative changes in patients with clinical history of bipolar disorders. Neuropathology. 2015 Jun;35 (3):245-53.","DOI":"10.1111\/neup.12191"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nagao S, Yokota O, Ikeda C, et al. Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264 (4):317-31.","DOI":"10.1007\/s00406-013-0472-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nishida N, Hata Y, Yoshida K, Kinoshita K. Neuropathologic features of suicide victims who presented with acute poststroke depression: Significance of association with neurodegenerative disorders. J Neuropathol Exp Neurol. 2015 May;74 (5):401-10.","DOI":"10.1097\/NEN.0000000000000184"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Benussi A, Alberici A, Samra K, et al. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimers Dement. 2022 Jul;18 (7):1408-23.","DOI":"10.1002\/alz.12485"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020 Apr 28;94 (17):743-55.","DOI":"10.1212\/WNL.0000000000009323"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vardy E, Holt R, Gerhard A, Richardson A, Snowden J, Neary D. History of suspected delirium is more common in dementia with Lewy bodies than Alzheimer&apos;s disease: A retrospective study. Int J Geriatr Psychiatry. 2014 Feb;29 (2):178-81.","DOI":"10.1002\/gps.3986"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Novais F, Starkstein S. Phenomenology of depression in Alzheimer&apos;s disease. J Alzheimers Dis. 2015;47 (4):845-55.","DOI":"10.3233\/JAD-148004"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Ag\u00fcera-Ortiz L, Garc\u00eda-Ramos R, Grandas P\u00e9rez FJ, et al. Depression in Alzheimer&apos;s disease: A Delphi consensus on etiology, risk factors, and clinical management. Front Psychiatry. 2021 Feb 26;12:638651. doi: 10.3389\/fpsyt.2021.638651. eCollection 2021.","DOI":"10.3389\/fpsyt.2021.638651"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Butters MA, Young JB, Lopez O, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10 (3):345-57.","DOI":"10.31887\/DCNS.2008.10.3\/mabutters"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005 Dec 27;65 (12):1863-72.","DOI":"10.1212\/WNL.65.12.1992-a"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takahashi S, Mizukami K, Yasuno F, Asada T. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy. Psychogeriatrics. 2009 Jun;9 (2):56-61.","DOI":"10.1111\/j.1479-8301.2009.00292.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020 Apr 28;94 (17):743-55.","DOI":"10.1212\/WNL.0000000000009323"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Berg D, Borghammer P, Fereshtehnejad SM, et al. Profromal Parkinson disease subtypes-key to understanding heterogeneity. Nat Rev Neurol. 2021 Jun;17 (6):349-61.","DOI":"10.1038\/s41582-021-00486-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Roselli F, Pisciotta NM, Perneczky R, et al. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I-FP-CIT SPECT study. Mov Disord. 2009 Oct 30;24 (14):2097-103.","DOI":"10.1002\/mds.22702"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sharp SI, Ballard CG, Ziabreva I, et al. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson&apos;s disease dementia. Dement Geriatr Cogn Disord. 2008;26 (4):330-8.","DOI":"10.1159\/000161058"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson&apos;s disease. Brain Res. 1990 Feb 26;510 (1):104-7.","DOI":"10.1016\/0006-8993(90)90733-R"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Miquel-Rio L, Alarc\u00f3n-Aris D, Torres-L\u00f3pez M, et al. Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Transl Psychiatry. 2022 Feb 24;12 (1):79. doi: 10.1038\/s41398-022-01842-z","DOI":"10.1038\/s41398-022-01842-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cheran G, Silverman H, Manoochehri M, et al. Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in <i>MAPT<\/i> mutation carriers. J Neurol Neurosurg Psychiatry. 2018 May;89 (5):449-55.","DOI":"10.1136\/jnnp-2017-317263"},{"key":"27","unstructured":"27. Benussi A, Premi E, Gazzina S, et al. Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia. JAMA Netw Open. 2021 Jan 4;4 (1):e2030194. doi: 10.1001\/jamanetworkopen.2020.20194"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sha SJ, Takada LT, Rankin KP, et al. Frontotemporal dementia due to C9ORF72 mutations: Clinical and imaging features. Neurology. 2012 Sep 4;79 (10):1002-11.","DOI":"10.1212\/WNL.0b013e318268452e"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Snowden J, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012 Mar;135 (Pt 3):693-708.","DOI":"10.1093\/brain\/awr355"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Scarioni M, Gami-Patel P, Timar Y, et al. Frontotemporal dementia: correlations between psychiatric symptoms and pathology. Ann Neurol. 2020 Jun;87 (6):950-61.","DOI":"10.1002\/ana.25739"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Darweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of prediagnostic functioning in Parkinson&apos;s disease. Brain. 2017 Feb;140 (2):429-41.","DOI":"10.1093\/brain\/aww291"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Marsh L. Depression and Parkinson&apos;s disease: current knowledge. Curr Neurol Neurosci Rep. 2013 Dec;13 (12):409. doi: 10.1007\/\/s11910-013-0409-5","DOI":"10.1007\/s11910-013-0409-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Goldman JG, Postuma R. Premotor and nonmotor features of Parkinson&apos;s disease. Curr Opin Neurol. 2014 Aug;27 (4):434-41.","DOI":"10.1097\/WCO.0000000000000112"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Todorova A, Jenner P, Ray Chaudhuri K. Non-motor Parkinson&apos;s: Integral to motor Parkinson&apos;s, yet often neglected. Pract Neurol. 2014 Oct;14 (5):310-22.","DOI":"10.1136\/practneurol-2013-000741"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Gustafsson H, Nordstr\u00f6m A, Nordstr\u00f6m P. Depression and subsequent risk of Parkinson disease: A nationwide cohort study. Neurology. 2015 Jun 16;84 (24):2422-9.","DOI":"10.1212\/WNL.0000000000001684"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson&apos;s disease. Mov Disord. 2008 Jan 30;23 (2):183-9.","DOI":"10.1002\/mds.21803"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Fearnley JM, Lees AJ. Ageing and Parkinson&apos;s disease: Substantia nigra regional selectivity. Brain. 1991 Oct;114 (Pt 5):2283-301.","DOI":"10.1093\/brain\/114.5.2283"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Postuma RB, Aarsland D, Barone P, et al. Identifying prodromal Parkinson&apos;s disease: Pre-motor disorders in Parkinson&apos;s disease. Mov Disord. 2012 Apr 15;27 (5):617-26.","DOI":"10.1002\/mds.24996"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Ni R, Nitsch RM. Recent developments in positron emission tomography tracers for proteinopathies imaging in dementia. Front Aging Neurosci. 2022 Jan 3;13:751897. doi: 10.3389\/fnagi.2021.751897","DOI":"10.3389\/fnagi.2021.751897"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tateno A, Sakayori T, Okubo Y. Amyloid positron emission tomography imaging for the differential diagnosis of Alzheimer&apos;s disease. J Nippon Med Sch. 2014;81 (1):2-3.","DOI":"10.1272\/jnms.81.2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tateno A, Sakayori T, Higuchi M, et al. Amyloid imaging with [ (18) F]florbetapir in geriatric depression: Early-onset versus late-onset. Int J Geriatr Psychiatry. 2015 Jul;30 (7):720-8.","DOI":"10.1002\/gps.4215"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Pagni G, Tagliarini C, Carbone MG, Imbimbo BP, Marazziti D, Pomara N. Different sides of depression in the elderly: An in-depth view on the role of A\u03b2 peptides. Curr Med Chem. 2022;29 (36):5731-57. doi: 10.2174\/0929867328666210921164816","DOI":"10.2174\/0929867328666210921164816"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Taniguchi-Watanabe S, Arai T, Kametani F, et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-inosoluble and trypsin-resistant tau. Acta Neuropathol. 2016 Feb;131 (2):267-80.","DOI":"10.1007\/s00401-015-1503-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Gatchel JR, Donovan NJ, Locascio JJ, et al. Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: A pilot study. J Alzheimers Dis. 2017;59 (3):975-85.","DOI":"10.3233\/JAD-170001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Moriguchi S, Takahata K, Shimada H, et al. Excess tau PET ligand retention in elderly patients with major depressive disorder. Mol Psychiatry. 2021 Oct;26 (10):5856-63.","DOI":"10.1038\/s41380-020-0766-9"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Maltais DD, Jordan LG, Min HK, et al. Confirmation of 123I-FP-CIT SPECT quantification methods in dementia with Lewy bodies and other neurodegenerative disorders. J Nucl Med. 2020 Nov;61 (11):1628-35.","DOI":"10.2967\/jnumed.119.239418"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014 Dec;10 (12):708-22.","DOI":"10.1038\/nrneurol.2014.205"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Levigoureux E, Lancelot S, Bouillot C, et al. Binding of the PET radiotracer [18F]BF227 dose not reflect the presence of alpha-synuclein aggregates in transgenic mice. Curr Alzheimer Res. 2014;11 (10):955-60.","DOI":"10.2174\/1567205011666141107154201"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Miranda-Azpiazu P, Svedberg M, Higuchi M, et al. Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein. Brain Res. 2020 Dec 15;1749:147131. doi: 10.1016\/j.brainres.2020.147131","DOI":"10.1016\/j.brainres.2020.147131"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Matsuoka K, Ono M, Takado Y, et al. High-contrast imaging of \u03b1-synuclein pathologies in living patients with multiple system atrophy. Mov Disord. 2022 Oct;37 (10):2159-61. doi: 10.1002\/mds.29186","DOI":"10.1002\/mds.29186"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/2\/90_JNMS.2023_90-216\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:57:10Z","timestamp":1715317030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/2\/90_JNMS.2023_90-216\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2023_90-216","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"article-number":"JNMS.2023_90-216"}}